4536 — Santen Pharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00- ¥537bn
- ¥515bn
- ¥279bn
- 96
- 55
- 98
- 98
Annual cashflow statement for Santen Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 31,943 | 21,714 | 6,645 | 27,189 | -14,983 |
| Depreciation | |||||
| Non-Cash Items | 6,364 | 14,368 | 46,010 | 8,253 | 47,577 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -16,382 | -12,708 | -30,615 | -6,454 | -12,696 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 32,894 | 39,947 | 38,808 | 46,043 | 37,147 |
| Capital Expenditures | -8,333 | -9,228 | -23,804 | -35,841 | -24,588 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 5,398 | 4,053 | -29,551 | 672 | -2,189 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2,935 | -5,175 | -53,355 | -35,169 | -26,777 |
| Financing Cash Flow Items | 128 | -446 | 148 | 147 | 445 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -28,107 | -12,729 | -16,685 | 5,557 | -37,220 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1,514 | 20,633 | -28,542 | 20,125 | -25,111 |